MORRISVILLE, N.C.--(BUSINESS WIRE)--etrials Worldwide, Inc. (Nasdaq: ETWC), a leading provider of adaptive eClinical software and services that optimize clinical trial management by turning data into intelligence and shortening the pathway to an actionable study endpoint, announced today that the board of directors has appointed M. Denis Connaghan as the company’s president and chief executive officer. Mr. Connaghan replaces Chuck Piccirillo, etrials’ vice president of technology, who has served as interim president and chief executive officer since July 10.
